Free Trial

Veradigm (NASDAQ:MDRX) Shares Gap Up - Here's What Happened

Veradigm logo with Business Services background

Shares of Veradigm Inc. (NASDAQ:MDRX - Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $9.40, but opened at $10.00. Veradigm shares last traded at $10.00, with a volume of 3,447 shares.

Wall Street Analysts Forecast Growth

Separately, StockNews.com started coverage on shares of Veradigm in a research note on Thursday, December 19th. They issued a "hold" rating on the stock. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $11.75.

Read Our Latest Analysis on MDRX

Veradigm Trading Down 1.1 %

The company has a fifty day simple moving average of $9.99 and a two-hundred day simple moving average of $9.73.

Institutional Investors Weigh In On Veradigm

A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC bought a new stake in Veradigm Inc. (NASDAQ:MDRX - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 3,974 shares of the software maker's stock, valued at approximately $38,000.

About Veradigm

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Further Reading

Should you invest $1,000 in Veradigm right now?

Before you consider Veradigm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.

While Veradigm currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Energy Stocks Are Poised for Explosive Growth in 2025
From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines